Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma.
Clin Exp Med. 2024 Apr 29;24(1):90. doi: 10.1007/s10238-024-01347-7.
Clin Exp Med. 2024.
PMID: 38683232
Free PMC article.
Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma.
Yuti P, Sawasdee N, Natungnuy K, Rujirachaivej P, Luangwattananun P, Sujjitjoon J, Yenchitsomanus PT.
Yuti P, et al. Among authors: rujirachaivej p.
Biomed Pharmacother. 2023 Dec;168:115691. doi: 10.1016/j.biopha.2023.115691. Epub 2023 Oct 14.
Biomed Pharmacother. 2023.
PMID: 37844355
Free article.
Item in Clipboard
Coinheritance of Hb A2-Melbourne (HBD: c.130G>A) and Hb E (HBB: c.79G>A) in Laos and Simultaneous High Resolution Melt Detection of Hb A2-Melbourne and Hb A2-Lampang (HBD: c.142G>A) in a Single Tube.
Jomoui W, Panichchob P, Rujirachaivej P, Panyasai S, Tepakhan W.
Jomoui W, et al. Among authors: rujirachaivej p.
Hemoglobin. 2019 May;43(3):214-217. doi: 10.1080/03630269.2019.1651332. Epub 2019 Aug 26.
Hemoglobin. 2019.
PMID: 31450984
Item in Clipboard
The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome.
Rujirachaivej P, Siriboonpiputtana T, Rerkamnuaychoke B, Magmuang S, Chareonsirisuthigul T, Boonsakan P, Petvises S, Sirirat T, Niparuck P, Chuncharunee S.
Rujirachaivej P, et al.
Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1825-1831. doi: 10.22034/APJCP.2018.19.7.1825.
Asian Pac J Cancer Prev. 2018.
PMID: 30049194
Free PMC article.
Item in Clipboard
Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.
Limsuwanachot N, Rerkamnuaychoke B, Chuncharunee S, Pauwilai T, Singdong R, Rujirachaivej P, Chareonsirisuthigul T, Siriboonpiputtana T.
Limsuwanachot N, et al. Among authors: rujirachaivej p.
Hematology. 2017 Dec;22(10):599-606. doi: 10.1080/10245332.2017.1312736. Epub 2017 Apr 13.
Hematology. 2017.
PMID: 28406068
Item in Clipboard
Cite
Cite